<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Open Fractures and Antibiotics</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->1/20/2012</div></div><div class="card__content"><h1 id="open-fractures-and-antibiotics">Open Fractures and Antibiotics</h1>
<h2 id="gustilo-classification-for-open-fractures">Gustilo Classification for Open Fractures</h2>
<p><strong>Type I:</strong> Open fracture with skin wound &lt; 1 cm and clean</p>
<p><strong>Type II:</strong> Open fracture skin laceration &gt; 1 cm without extensive soft tissue damage, flaps, or avulsion </p>
<p><strong>Type III:</strong>  Open fracture with extensive soft tissue injury or traumatic amputation (includes gun shot wounds and farm injuries)</p>
<ul>
<li><strong>IIIA:</strong> Adequate tissue coverage</li>
<li><strong>IIIB:</strong> Significant soft tissue loss with exposed bone that will require skin graft</li>
<li><strong>IIIC:</strong> Associated vascular injury requiring repair for limb preservation </li>
</ul>
<h2 id="level-i-recommendations">Level I Recommendations</h2>
<ul>
<li>Start systemic antibiotics ASAP and target gram-positive organisms (eg. first generation cephalosporins)</li>
<li>Add antibiotics for gram-negative fractures for Type III open fractures</li>
<li>Add <span class="drug">high-dose penicillin</span>, if fecal or potential clostridial contamination (e.g. farm-related injuries)</li>
<li><span class="drug">Fluoroquinolones</span> provide no added benefit compared to the <span class="drug">cephalosporin + aminoglycoside</span> combination. Fluoroquinolones may impair fracture healing and result in higher infection rates in type III open fractures. </li>
</ul>
<h2 id="level-ii-recommendations">Level II Recommendations</h2>
<ul>
<li><strong>Type III fractures</strong>: Continue antibiotics for 72 hours post-injury, or not &gt;24 hours after soft tissue coverage achieved</li>
<li>Once-daily aminoglycoside dosing is safe and effective for type II and III fractures </li>
</ul>
<h2 id="references">References</h2>
<ul>
<li>Hoff WS, Bonadies JA, Cachecho R, Dorlac WC. EAST Practice Management Guidelines Work Group: update to practice management guidelines for prophylactic antibiotic use in open fractures. J Trauma. 2011 Mar;70(3):751-4. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21610369">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"open-fractures","title":"Open Fractures and Antibiotics","authors":["Michelle Lin, MD"],"categories":[{"slug":"orthopedics","name":"Orthopedics"},{"slug":"infectious-disease","name":"Infectious Disease"}],"created":"2012/01/20","updated":null,"body":"\n# Open Fractures and Antibiotics\n\n## Gustilo Classification for Open Fractures\n\n**Type I:** Open fracture with skin wound \u0026lt; 1 cm and clean\n\n**Type II:** Open fracture skin laceration \u003e 1 cm without extensive soft tissue damage, flaps, or avulsion \n\n**Type III:**  Open fracture with extensive soft tissue injury or traumatic amputation (includes gun shot wounds and farm injuries)\n\n- **IIIA:** Adequate tissue coverage\n- **IIIB:** Significant soft tissue loss with exposed bone that will require skin graft\n- **IIIC:** Associated vascular injury requiring repair for limb preservation \n\n## Level I Recommendations\n\n- Start systemic antibiotics ASAP and target gram-positive organisms (eg. first generation cephalosporins)\n- Add antibiotics for gram-negative fractures for Type III open fractures\n- Add \u003cspan class=\"drug\"\u003ehigh-dose penicillin\u003c/span\u003e, if fecal or potential clostridial contamination (e.g. farm-related injuries)\n- \u003cspan class=\"drug\"\u003eFluoroquinolones\u003c/span\u003e provide no added benefit compared to the \u003cspan class=\"drug\"\u003ecephalosporin + aminoglycoside\u003c/span\u003e combination. Fluoroquinolones may impair fracture healing and result in higher infection rates in type III open fractures. \n\n## Level II Recommendations\n\n- **Type III fractures**: Continue antibiotics for 72 hours post-injury, or not \u003e24 hours after soft tissue coverage achieved\n- Once-daily aminoglycoside dosing is safe and effective for type II and III fractures \n\n## References\n\n- Hoff WS, Bonadies JA, Cachecho R, Dorlac WC. EAST Practice Management Guidelines Work Group: update to practice management guidelines for prophylactic antibiotic use in open fractures. J Trauma. 2011 Mar;70(3):751-4. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=21610369)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"open-fractures"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>